Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis

@inproceedings{Guckenberger2014SafetyAE,
  title={Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis},
  author={Matthias Guckenberger and F. J. A. M. van Houten Dr. J. C. W. van Ommeren Ir. R Mantel and Peter Carlos Gerszten and J C Flickinger and Arjun Sahgal and Daniel L{\'e}tourneau and Inga Siiner Grills and Maha Saada Jawad and Daniel K. Fahim and John H. Shin and Brian A Winey and Jason P Sheehan and Ron Kersh},
  booktitle={Radiation oncology},
  year={2014}
}
PURPOSE To evaluate patient selection criteria, methodology, safety and clinical outcomes of stereotactic body radiotherapy (SBRT) for treatment of vertebral metastases. MATERIALS AND METHODS Eight centers from the United States (n=5), Canada (n=2) and Germany (n=1) participated in the retrospective study and analyzed 301 patients with 387 vertebral metastases. No patient had been exposed to prior radiation at the treatment site. All patients were treated with linac-based SBRT using cone-beam… CONTINUE READING